Pharmosa Biopharm (ROCO:6875) FCF Yield % : -0.60 (As of Jun. 06, 2024)

Pharmosa Biopharm FCF Yield % Chart

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial									-1.91	-2.31	8.80	-5.73	-2.51

Competitive Comparison of Pharmosa Biopharm's FCF Yield %

For the Biotechnology subindustry, Pharmosa Biopharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's FCF Yield % falls into.

Pharmosa Biopharm FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Pharmosa Biopharm's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

Pharmosa Biopharm's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Pharmosa Biopharm FCF Yield % Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm (ROCO:6875) Business Description